Tilray Should Be Cut From Your Portfolio
Summary: Tilray’s stock price has fallen 18.3% in 2024, lagging behind the market and its
Summary: Tilray’s stock price has fallen 18.3% in 2024, lagging behind the market and its
Summary: Tilray’s stock has dropped 20% since the start of 2024, losing nearly 90% of
Summary: Canadian cannabis and beverage firm Tilray has struggled with missed revenue estimates, large losses,
Summary: Tilray Brands consistently misses quarterly targets and lacks organic growth. Tilray’s revenue for FQ3
Summary: Tilray’s stock has bounced back by 55% since mid-November but is down 11% since
Summary: Recently introduced German cannabis laws will make it easier to obtain medical and therapeutic
Summary: Tilray Brands, Inc.’s growth is driven by acquisitions, not organic growth in the cannabis
Summary: Tilray reported Q2 revenue of $194 million, up 34% YoY but slightly below analyst
Summary: Tilray Brands, Inc. shares dropped 9.4% after falling short of revenue and GAAP earnings
Summary: Tilray stock dipped following the release of second-quarter earnings. The company’s ambitions to enter